Pharma Mar (OTCMKTS:PHMMF) Shares Gap Up – Still a Buy?

Pharma Mar (OTCMKTS:PHMMF) gapped up prior to trading on Monday . The stock had previously closed at $96.00, but opened at $106.15. Pharma Mar shares last traded at $106.4775, with a volume of 10,300 shares trading hands.

Pharma Mar Stock Performance

The stock’s 50 day moving average is $92.30 and its 200 day moving average is $91.20. The company has a quick ratio of 2.44, a current ratio of 3.02 and a debt-to-equity ratio of 0.14.

About Pharma Mar

PharmaMar is a Spain-based biopharmaceutical company that specializes in the discovery and development of novel oncology therapies derived from marine organisms. Founded in 1986 as part of Grupo Zeltia, the company has pioneered the use of compounds extracted from deep-sea organisms to create synthetic analogs aimed at treating various forms of cancer. Its core expertise lies in marine biotechnology, medicinal chemistry and oncology-focused clinical development.

The company’s flagship product is Yondelis (trabectedin), an antitumor agent approved in the European Union for the treatment of soft tissue sarcoma and relapsed platinum-sensitive ovarian cancer.